Ryan Charles S. 4

4 · BioRestorative Therapies, Inc. · Filed Mar 25, 2019

Form 4

Period: 2019-03-25

Director

Transactions

Award
Option
2019-03-25+20,000→ 20,000 total
Exercise: $0.75Exp: 2025-09-04→ Common Stock (20,000 underlying)
Award
Option
2019-03-25+15,000→ 15,000 total
Exercise: $0.75Exp: 2025-04-06→ Common Stock (15,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−100,000→ 0 total
Exercise: $3.35Exp: 2027-06-23→ Common Stock (100,000 underlying)
Award
Stock Option
2019-03-25+75,000→ 75,000 total
Exercise: $0.75Exp: 2028-10-29→ Common Stock (75,000 underlying)
Disposition to Issuer
Option
2019-03-25−15,000→ 0 total
Exercise: $4.70Exp: 2025-04-06→ Common Stock (15,000 underlying)
Disposition to Issuer
Option
2019-03-25−20,000→ 0 total
Exercise: $4.70Exp: 2025-09-04→ Common Stock (20,000 underlying)
Disposition to Issuer
Option
2019-03-25−46,000→ 0 total
Exercise: $3.73Exp: 2026-06-10→ Common Stock (46,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−75,000→ 0 total
Exercise: $1.23Exp: 2028-10-29→ Common Stock (75,000 underlying)
Award
Option
2019-03-25+46,000→ 46,000 total
Exercise: $0.75Exp: 2026-06-10→ Common Stock (46,000 underlying)
Award
Stock Option
2019-03-25+100,000→ 100,000 total
Exercise: $0.75Exp: 2027-06-23→ Common Stock (100,000 underlying)

Holdings

Common Stock
42,917
Warrant
Exercise: $15.00From: 2015-05-08Exp: 2020-05-08→ Common Stock (2,500 underlying)
2,500
Warrant
Exercise: $4.00From: 2017-03-01Exp: 2022-03-01→ Common Stock (26,667 underlying)
26,667
Warrant
Exercise: $4.00From: 2015-12-07Exp: 2020-11-12→ Common Stock (6,250 underlying)
6,250

Footnotes (6)

[F1]The option vests to the extent of 5,000 shares on each of April 6, 2016, April 6, 2017 and April 6, 2018.
[F2]The option is exercisable to the extent of 10,000 shares on December 22, 2015, 3,334 shares on September 4, 2016, and 3,333 shares on each of September 4, 2017 and September 4, 2018.
[F3]The option is exercisable to the extent of 15,334 shares on June 10, 2016 and 15,333 shares on each of June 10, 2017 and June 10, 2018.
[F4]The option is exercisable to the extent of 33,334 shares on June 23, 2017, and 33,333 shares on each of June 23, 2018 and June 23, 2019.
[F5]The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020.
[F6]The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price.

Documents

1 file